UA105164C2 - Substituted 8-[6-amino-3-pyridyl]xanthines - Google Patents

Substituted 8-[6-amino-3-pyridyl]xanthines

Info

Publication number: UA105164C2
Authority: UA; Ukraine
Prior art keywords: xanthines; pyridyl; amino; substituted; compositions
Prior art date: 2006-06-16

Application number

UAA200900239A

Other languages

English (en)

Russian (ru)

Ukrainian (uk)

Inventor

Гуокьюан Вонг

Роберт Д. Томпсон

Джейсон М. Ригер

Original Assignee

Догвуд Фармасьютикалз, Инк

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-06-16

Filing date

2007-06-13

Publication date

2014-04-25

2007-06-13 Application filed by Догвуд Фармасьютикалз, Инк filed Critical Догвуд Фармасьютикалз, Инк

2014-04-25 Publication of UA105164C2 publication Critical patent/UA105164C2/ru

Links

DIVYESOURJTWDY-UHFFFAOYSA-N 8-(6-aminopyridin-3-yl)-3,7-dihydropurine-2,6-dione Chemical class C1=NC(N)=CC=C1C(N1)=NC2=C1C(=O)NC(=O)N2 DIVYESOURJTWDY-UHFFFAOYSA-N 0.000 title abstract 2
108050000203 Adenosine receptors Proteins 0.000 abstract 1
102000009346 Adenosine receptors Human genes 0.000 abstract 1
101150078577 Adora2b gene Proteins 0.000 abstract 1
239000005557 antagonist Substances 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
239000008177 pharmaceutical agent Substances 0.000 abstract 1
239000008194 pharmaceutical composition Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

UAA200900239A 2006-06-16 2007-06-13 Substituted 8-[6-amino-3-pyridyl]xanthines UA105164C2 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US80503006P	2006-06-16	2006-06-16
PCT/US2007/013849 WO2007149277A2 (fr)	2006-06-16	2007-06-13	8-[6-amino-3-pyridyl]xanthines substituées

Publications (1)

Publication Number	Publication Date
UA105164C2 true UA105164C2 (en)	2014-04-25

Family

ID=38833978

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
UAA200900239A UA105164C2 (en)	2006-06-16	2007-06-13	Substituted 8-[6-amino-3-pyridyl]xanthines

Country Status (4)

Country	Link
CN (1)	CN101466382A (fr)
UA (1)	UA105164C2 (fr)
WO (1)	WO2007149277A2 (fr)
ZA (1)	ZA200900259B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP5460690B2 (ja)	2008-03-26	2014-04-02	アドヴィナス・セラピューティックス・リミテッド	アデノシンレセプターアンタゴニストとしてのヘテロ環化合物
AU2010222289B2 (en)	2009-03-13	2013-07-11	Advinus Therapeutics Private Limited	Substituted fused pyrimidine compounds
EP2499142B1 (fr)	2009-11-09	2016-09-21	Advinus Therapeutics Limited	Composés pyrimidine fusionnés substitués, leur préparation et leurs utilisations
CN103261200B (zh)	2010-09-13	2016-03-30	阿迪维纳斯疗法有限公司	作为a2b腺苷受体拮抗剂的前药的嘌呤化合物、它们的制备方法及医药用途
MX2021008094A (es)	2019-01-11	2021-09-21	Omeros Corp	Metodos y composiciones para el tratamiento del cancer.
BR112023023996A2 (pt) *	2021-05-18	2024-01-30	Adovate Llc	Xantinas de piridil contendo amida cíclica como antagonistas de a2b

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4938949A (en)	1988-09-12	1990-07-03	University Of New York	Treatment of damaged bone marrow and dosage units therefor
KR101222364B1 (ko) *	2003-08-25	2013-01-15	트로비스 파마슈티칼스 엘엘씨	치환된 8-헤테로아릴 크산틴

2007
- 2007-06-13 WO PCT/US2007/013849 patent/WO2007149277A2/fr not_active Ceased
- 2007-06-13 CN CNA2007800222077A patent/CN101466382A/zh active Pending
- 2007-06-13 UA UAA200900239A patent/UA105164C2/ru unknown
2009
- 2009-01-13 ZA ZA200900259A patent/ZA200900259B/xx unknown

Also Published As

Publication number	Publication date
WO2007149277A3 (fr)	2008-02-21
CN101466382A (zh)	2009-06-24
WO2007149277A2 (fr)	2007-12-27
ZA200900259B (en)	2010-09-29

Similar Documents

Publication	Publication Date	Title
WO2005021548A3 (fr)	2005-06-30	Xanthines de 8-heteroaryle substituees
MY152178A (en)	2014-08-15	Substituted 8-[6-amino-3-pyridyl]xanthines
ZA200800353B (en)	2008-12-31	Pyrazine derivatives useful as adenosine receptor antagonists
WO2006091898A3 (fr)	2007-02-22	Xanthines substituees par pyrazolyle
IL178396A0 (en)	2007-02-11	Condensed pyridine derivatives useful as a28 adenosine receptor antagonists
WO2008031556A3 (fr)	2008-06-12	Nouveaux dérivés de la 2-amino-pyrimidine, procédés pour les préparer, compositions pharmaceutiques les contenant
WO2000073307A8 (fr)	2002-02-28	8-phenylxanthines substituees utiles comme antagonistes de recepteurs de l'adenosine a¿2b?
WO2008021851A3 (fr)	2008-06-26	Nouveaux composés comme antagonistes ou agonistes inverses pour les récepteurs d'opioïdes
ZA200710878B (en)	2009-05-27	Prodrugs of A2B adenosine receptor antagonists
IL178365A0 (en)	2007-02-11	Selective antagonists of a2a adenosine receptors
BRPI0813218A2 (pt)	2014-12-23	Composto, composição farmacêutica que o contém como princípio ativo e uso do composto.
ATE461932T1 (de)	2010-04-15	Pyrazoloä4,3-eü-1,2,4-triazoloä1,5-cüpyrimidine als antagonisten des adenosin-a2a-rezeptors
MX2010006645A (es)	2010-10-05	Esteres del acido 4-{3-[6-amino-9-(3,4-dihidroxi-tetrahidro-furan- 2-il)-9h-purin-2-il]-prop-2-inil}-piperidin-1-carboxilico sustituidos como agonistas del r a2a.
UA105164C2 (en)	2014-04-25	Substituted 8-[6-amino-3-pyridyl]xanthines
WO2008011007A3 (fr)	2008-09-25	Antagonistes sélectifs des récepteurs de l'adénosine a2a
EP2032797A4 (fr)	2011-03-16	Antagonistes du récepteur de l'adénosine a2b
ATE458740T1 (de)	2010-03-15	1,4,5,6,7,8-hexahydro-1,2,5-triaza-azulen- derivate als orexinrezeptor-antagonisten
WO2005040155A8 (fr)	2006-04-20	Derives de pyrimidin-2-amine et utilisation de ceux-ci en tant qu'antagonistes du recepteur de l'adenosine a2b
WO2008027585A3 (fr)	2008-09-25	Pyrrolo[3,2-d]pyrimidines antagonistes sélectifs des récepteurs de l'adénosine a2b
WO2008116185A3 (fr)	2009-03-12	Pyrimidines substituées utilisées comme antagonistes des récepteurs de l'adénosine
MXPA05011860A (es)	2006-02-17	Derivados de xantina como antagonistas del receptor de adenosina a2b.
WO2006091936A3 (fr)	2008-12-04	Procedes permettant d'effectuer la synthese de xanthines a substitution cycloalkyle dissymetrique
MX2012000113A (es)	2012-02-29	Compuestos alcoxi-carbonil-amino-alquinil-adenosina y derivados de los mismos como agonistas a2ar.
IL185235A0 (en)	2008-02-09	Highly potent full and partial agonists and antagonists of the nociceptin/orphanin fq receptor
ZA200900627B (en)	2010-09-29	Selective antagonists of A2A adenosine receptors